In vitro and in vivo profiling of CHF5022 and CHF5074-Reference-Cited by-同舟云学术

In vitro and in vivo profiling of CHF5022 and CHF5074

Published:2007-04 Issue:4 Volume:55 Page:318-328
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Imbimbo Bruno P.,Del Giudice Elda,Cenacchi Valentina,Volta Roberta,Villetti Gino,Facchinetti Fabrizio,Riccardi Benedetta,Puccini Paola,Moretto Nadia,Grassi Francesca,Ottonello Simone,Leon Alberta

Publisher

Elsevier BV

Subject

Pharmacology

Reference43 articles.

1. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity;Weggen;Nature,2001

2. Selective inhibition of Aβ42 production by NSAID R-enantiomers;Morihara;J Neurochem,2002

3. NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo;Eriksen;J Clin Invest,2003

4. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease;Lim;J Neurosci,2000

5. Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice;Lim;Neurobiol Aging,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases;Journal of Personalized Medicine;2021-12-04

2. Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin;Journal of Structural Biology;2019-11

3. γ-Secretase and its modulators: Twenty years and beyond;Neuroscience Letters;2019-05

4. Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents;Nitric Oxide;2019-03

5. The potential of signal peptide peptidase as a therapeutic target for hepatitis C;Expert Opinion on Therapeutic Targets;2017-08-22